Understanding biosimilars, biologics, and the challenges surrounding their regulation and pricing in the pharmaceutical ...

Ontruzant, the first biosimilar version of Roche’s Herceptin (trastuzumab) in Europe has been launched in the UK by MSD. Developed by Korean biosimilar specialists Samsung Bioepsis, MSD is the ...

That changed with the next two biosimilars to come online, which were versions of the cancer drugs MabThera (rituximab) and Herceptin (trastuzumab). This time around incentives were put in place ...

Indian firms are also making strides in biosimilars, with over 100 products in development targeting oncology and autoimmune diseases. Biocon’s trastuzumab biosimilar and Dr. Reddy’s rituximab ...

Hyderabad: Aurobindo Pharma has announced that the European Commission (EC) has granted marketing authorization in the ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

Biosimilar Litigations include litigations relating to biosimilar/follow-on products of CDER-listed reference products. Litigations between biosimilar applicants/manufacturers and reference ...

Samsung Bioepis received approval for two biosimilars of denosumab that are interchangeable with Prolia and Xgeva. Ospomyv provided similar BMD increases as Prolia for women with osteoporosis in a ...

High uptake of RSVpreF vaccine and nirsevimab was observed, with 64% of pregnant individuals and 70% of infants receiving them. Factors such as older maternal age, private insurance, and receipt ...

Induction therapy with ixekizumab may provide faster symptom relief but is associated with lower long-term drug survival due to higher baseline disease severity. The study analyzed 183 patients ...